SCHEMBL18872101

SCHEMBL18872101

CC(C)(C)OCCN(CCO)CC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788337 0.84 MAPT (0.32) —
SCHEMBL18872104 0.83 — —
SCHEMBL18776612 0.81 MLYCD (0.30) —
SCHEMBL18859438 0.79 CYP1A2 (0.42) —
SCHEMBL13472100 0.77 TSHR (0.33) —
SCHEMBL20887301 0.74 CYP1A2 (0.37) —
SCHEMBL18871974 0.74 — —
SCHEMBL15696999 0.72 — —
SCHEMBL12120262 0.72 MAPK1 (0.32) —
SCHEMBL13887600 0.70 MAPT (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170137420-A1 PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS P13K INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2017-05-18 — — US disclosed
Send feedback